BR9803717A - ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase. - Google Patents

ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase.

Info

Publication number
BR9803717A
BR9803717A BR9803717-0A BR9803717A BR9803717A BR 9803717 A BR9803717 A BR 9803717A BR 9803717 A BR9803717 A BR 9803717A BR 9803717 A BR9803717 A BR 9803717A
Authority
BR
Brazil
Prior art keywords
indole
transferase inhibitors
glucosyl transferase
acids substituted
carbocyclic acids
Prior art date
Application number
BR9803717-0A
Other languages
English (en)
Inventor
Susan Froshauer
Steven Wayne Goldstein
William George Stirtan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9803717A publication Critical patent/BR9803717A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Patente de Invenção: <B>''áCIDOS INDOL-2-CARBOXìLICOS SUBSTITUìDOS COMO INIBIDORES DE GLUCOSIL TRANSFERASE''<D>. ácidos 5-carbonilaril e 5-carbonilalquil e 5-carbonilcicloalquil-3-alquil-indol-2-carboxílicos são úteis como inibidores de UGGTase.
BR9803717-0A 1997-07-29 1998-07-28 ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase. BR9803717A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5414097P 1997-07-29 1997-07-29

Publications (1)

Publication Number Publication Date
BR9803717A true BR9803717A (pt) 2000-04-11

Family

ID=21989027

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9803717-0A BR9803717A (pt) 1997-07-29 1998-07-28 ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase.

Country Status (5)

Country Link
US (1) US5981762A (pt)
EP (1) EP0894789A1 (pt)
JP (1) JPH11100367A (pt)
BR (1) BR9803717A (pt)
CA (1) CA2243882A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155675B1 (en) 2007-06-12 2014-02-19 Provid Pharmaceuticals, Inc. Kinase inhibitors, compositions thereof, and methods of use therewith
CN104080452A (zh) 2011-10-26 2014-10-01 美国政府健康及人类服务部 用小分子chk2抑制剂治疗hcv感染的方法

Also Published As

Publication number Publication date
CA2243882A1 (en) 1999-01-29
JPH11100367A (ja) 1999-04-13
US5981762A (en) 1999-11-09
EP0894789A1 (en) 1999-02-03

Similar Documents

Publication Publication Date Title
BR9908280A (pt) Inibidores de enzimas de fosfolipase
DE69841285D1 (de) Bipolares Elektrodeninstrument
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
BR9808491A (pt) Compostos calcilìticos
BR9902086A (pt) Formulações farmacêuticas.
IT1311994B1 (it) Derivati di amminoacidi.
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
ATE546139T1 (de) Isoprentransferase proteine inhibitoren
BR9909242A (pt) Inibidores de fosfolipase a2
DE60010098D1 (de) 28-epirapaloge
ID24076A (id) Inhibitor-inhibitor protein transferase farnesil
BR9915515B1 (pt) composiÇço curÁvel de multicomponentes.
BR9810870A (pt) Regulação de expressão de quinolato fosforibosil transferase
PT842934E (pt) Agonistas de 5-ht1f
NO20004550D0 (no) Enzyminhibitorer
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
BR9608012A (pt) Agentes de amidino cíclicos úteis como inbidores da sintase do óxido nítrico
DE69935468D1 (de) Erzeugen von Nachrichtensignalen
ATA193098A (de) Elektrodensystem
DE69814309D1 (de) Niederspannungsverstärker
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
SE9801494D0 (sv) Novel use
ES2186807T3 (es) Inhibidores de trombina.
ITTO960386A0 (it) Elemento di minuteria per mobili.
ATE305517T1 (de) Neurotrypsin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1860 DE 29/08/2006.